Loading chat...

NH SB256

Bill

Status

Engrossed

2/26/2026

Primary Sponsor

Tim McGough

Click for details

Origin

Senate

2026 Regular Session

AI Summary

  • Requires written agreements between healthcare providers and pharmacies before insurers or pharmacy benefit managers (PBMs) can mandate "white bagging" (delivering drugs to providers for administration), including provider consent

  • Prohibits mandatory "brown bagging" (patients transporting drugs to providers) unless both patient and provider provide written consent and attest that transport will not compromise care

  • Prevents insurers and PBMs from imposing higher copays, fees, or coinsurance when patients obtain clinician-administered drugs from non-network pharmacies or pharmacies not selected by the insurer

  • Protects providers from reduced reimbursement when they obtain clinician-administered drugs from pharmacies outside the insurer's network or not managed by the PBM

  • Takes effect January 1, 2027, applying to outpatient prescription drugs that cannot be self-administered and must be given by a healthcare professional in a clinical setting

Legislative Description

Establishing safety and care requirements for clinician-administered drugs.

Last Action

Vacated and Referred to Commerce and Consumer Affairs (Rep. Kofalt): Motion Adopted Voice Vote (in recess of) 02/19/2026 House Journal 5

3/2/2026

Committee Referrals

Commerce and Consumer Affairs3/2/2026
Health, Human Services & Elderly Affairs2/26/2026
Health and Human Services1/23/2025

Full Bill Text

No bill text available